<DOC>
	<DOCNO>NCT01839799</DOCNO>
	<brief_summary>Determine relapse-free survival resect pancreatic cancer patient follow two novel regimen activity advance disease .</brief_summary>
	<brief_title>A Randomized Phase II/Genomic Trial Two Chemotherapy Regimens Patients With Resected Pancreatic Adenocarcinoma</brief_title>
	<detailed_description>The objective study determine relapse-free survival resect pancreatic cancer patient follow two novel regimen . The secondary objective 1 ) ass toxicity regimens set . 2 ) To perform exploratory genomic analysis mean assess molecular characteristic potentially associate risk relapse one regimens . 3 ) To determine relationship know mutation metabolic activity measure FDG-PET risk relapse .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patients must histologically cytologically confirm evidence pancreatic carcinoma . Patients must gross disease resect ( R0 R1 resection ) . Patients underwent R2 resection eligible . Patients must prior chemotherapy radiation therapy pancreatic cancer . Age &gt; 18 year . Patient must ECOG performance status 02 . Patients must normal organ marrow function measure within 2 week . prior registration follow : ANC &gt; 1,500/µL Platelets &gt; 100,000/µL Total bilirubim le 2fold ULN AST ( SGOT ) /ALT ( SGPT ) &lt; 2.5X institutional upper limit normal Creatinine clearance &gt; 60mL/min patient creatinine level institutional normal . Patients must &gt; 4 week &lt; 12 week postsurgery time study registration . Women childbearing potential sexually active male stronglt advise use appropriate contraceptive measure . Women must pregnant breastfeeding . All agent use study well radiation therapy abdomen potential teratogenic abortifacient effect . All female childbearing potential must blood test urine study within 2 week prior registration rule pregnancy . Patients must receive investigational agent . Patients know metastasis eligible . Patients wound fully heal eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Patients</keyword>
	<keyword />
	<keyword>resect</keyword>
</DOC>